Evidence map›Paper›PMID 37252969›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2023

17β-estradiol promotes extracellular vesicle release and selective miRNA loading in ERα-positive breast cancer.

Rares Drula, Barbara Pardini, Xiao Fu, Mireia Cruz De Los Santos, Ancuta Jurj, Lan Pang, Sherien M El-Daly, Linda Fabris, Erik Knutsen, Mihnea P Dragomir and 22 more

Open access · greenAbstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 30 papers.

0numbers the graph read from it
0cells of the map it votes in
30citing papers in PubMed
5.5field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

30 citing papers in PubMed, 36 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Review
  5. Review
  6. Review
  7. Review
  8. Article
  9. Review
  10. Review
  11. Article
  12. Review
  13. iScience · 2025
    Article
  14. Article
  15. Article
  16. Advancing Ischemic Stroke Prognosis: Key Role of MiR-155 Non-Coding RNA.International journal of molecular sciences · 2025
    Review
  17. Article
  18. Article
  19. Harnessing the Role ofInternational journal of molecular sciences · 2025
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

32 authors at 8 institutions in 8 countries.

Rares DrulaDepartment of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030.ORCID 0000-0001-7815-2766
Barbara PardiniItalian Institute for Genomic Medicine, c/o FPO-IRCCS Candiolo, 10060 Candiolo, Italy.ORCID 0000-0001-9571-4257
Xiao FuDepartment of Experimental Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, TX 77030.
Mireia Cruz De Los SantosDepartment of Experimental Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, TX 77030.ORCID 0000-0001-8349-8366
Ancuta JurjDepartment of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030.ORCID 0000-0001-7653-0620
Lan PangDepartment of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030.ORCID 0000-0002-5081-389X
Sherien M El-DalyDepartment of Experimental Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, TX 77030.ORCID 0000-0003-0049-8606
Linda FabrisDepartment of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030.ORCID 0000-0001-5763-0052
Erik KnutsenDepartment of Experimental Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, TX 77030.ORCID 0000-0002-4903-0150
Mihnea P DragomirDepartment of Experimental Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, TX 77030.ORCID 0000-0002-5550-3516
Recep BayraktarDepartment of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030.ORCID 0000-0002-8227-2055
Yongfeng LiDepartment of Experimental Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, TX 77030.
Meng ChenDepartment of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030.ORCID 0000-0002-2449-5904
Filippo Del VecchioUniversity of Hawaii Cancer Center, Cancer Biology Program, Honolulu, HI 96813.ORCID 0000-0003-1894-888X
Léa BerlandDepartment of Experimental Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, TX 77030.
Jessica DaeDepartment of Experimental Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, TX 77030.ORCID 0000-0002-0803-3072
Daniel FanDepartment of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030.
Masayoshi ShimizuDepartment of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030.
Anh M TranDepartment of Experimental Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, TX 77030.ORCID 0000-0003-0913-1536
Mercedes BarziDepartment of Pediatrics, Duke University, Durham, NC 27708.
Carlotta PioppiniDepartment of Experimental Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, TX 77030.ORCID 0000-0001-6461-2047
Angelica M GutierrezDepartment of Breast Medical Oncology, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX 77030.ORCID 0000-0002-8582-8186
Cristina IvanDepartment of Experimental Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, TX 77030.
Salyna MeasBreast Surgical Oncology, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX 77030.ORCID 0000-0001-5588-6337
Carolyn S HallBreast Surgical Oncology, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX 77030.ORCID 0000-0002-9416-2574
Suresh K AlahariDepartment of Biochemistry and Molecular Biology, Stanley S Scott Cancer Center, Louisiana State University School of Medicine, New Orleans, LA 70112.ORCID 0000-0002-9651-6727
Ioana Berindan-NeagoeThe Research Center for Functional Genomics, Biomedicine and Translational Medicine, Iuliu Hatieganu University of Medicine and Pharmacy, 400337 Cluj Napoca, Romania.ORCID 0000-0001-5828-1325
Muller FabbriUniversity of Hawaii Cancer Center, Cancer Biology Program, Honolulu, HI 96813.ORCID 0000-0002-8797-4793
Anthony LucciBreast Surgical Oncology, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX 77030.ORCID 0000-0003-4039-174X
Banu ArunDepartment of Breast Medical Oncology, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX 77030.
Simone AnfossiDepartment of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030.ORCID 0000-0001-5745-7587
George A CalinDepartment of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030.ORCID 0000-0002-7427-0578
The University of Texas MD Anderson Cancer Center · USUniversity of Hawaiʻi at Mānoa · USDuke University · USItalian institute for Genomic Medicine · ITIuliu Hațieganu University of Medicine and Pharmacy · ROKarolinska University Hospital · SELouisiana State University · USUniversity Hospital of North Norway · NO

Funding

Tropism Enhanced Oncolytic Adenovirus for the Treatment of Brain TumorsP50CA127001 · NCI · UNIVERSITY OF TX MD ANDERSON CAN CTR · PI Juan Fueyo · 2008 to 2026
$41.2M
Protein-coding and non-coding RNA biomarkers for early detection of CLLR01CA182905 · NCI · UNIVERSITY OF TX MD ANDERSON CAN CTR · PI ABRUZZO, LYNNE V., CALIN, GEORGE A. · 2014 to 2018
$2.9M
miR-155 targeted therapeutics for precision medicine in lung cancerR01CA222007 · NCI · UNIVERSITY OF TX MD ANDERSON CAN CTR · PI CALIN, GEORGE A., CRISTINI, VITTORIO · 2018 to 2022
$2.6M
Role of microRNAs released by Tumor Associated Macrophages within Exosomes in the chemoresistance of NeuroblastomaR01CA215753 · NCI · UNIVERSITY OF HAWAII AT MANOA · PI FABBRI, MULLER · 2017 to 2021
$1.7M
Clinical Significance and Mechanism of Action of Exosomal microRNAs in Neuroblastoma chemoresistanceR01CA219024 · NCI · UNIVERSITY OF HAWAII AT MANOA · PI FABBRI, MULLER · 2018 to 2022
$1.7M
Viral miRs and cellular miRs in sepsisR01GM122775 · NIGMS · UNIVERSITY OF TX MD ANDERSON CAN CTR · PI CALIN, GEORGE A., LUPU, FLOREA · 2018 to 2020
$1.1M
NCI NIH HHS P50 CA127001NCI NIH HHS R01 CA182905NCI NIH HHS R01 CA215753NCI NIH HHS R01 CA219024NCI NIH HHS R01 CA222007NIGMS NIH HHS R01 GM122775
6 · The paper itself

Abstract

The causes and consequences of abnormal biogenesis of extracellular vesicles (EVs) are not yet well understood in malignancies, including in breast cancers (BCs). Given the hormonal signaling dependence of estrogen receptor-positive (ER+) BC, we hypothesized that 17β-estradiol (estrogen) might influence EV production and microRNA (miRNA) loading. We report that physiological doses of 17β-estradiol promote EV secretion specifically from ER+ BC cells via inhibition of miR-149-5p, hindering its regulatory activity on SP1, a transcription factor that regulates the EV biogenesis factor nSMase2. Additionally, miR-149-5p downregulation promotes hnRNPA1 expression, responsible for the loading of let-7's miRNAs into EVs. In multiple patient cohorts, we observed increased levels of let-7a-5p and let-7d-5p in EVs derived from the blood of premenopausal ER+ BC patients, and elevated EV levels in patients with high BMI, both conditions associated with higher levels of 17β-estradiol. In brief, we identified a unique estrogen-driven mechanism by which ER+ BC cells eliminate tumor suppressor miRNAs in EVs, with effects on modulating tumor-associated macrophages in the microenvironment.

Indexed as

Breast NeoplasmsExtracellular VesiclesMicroRNAsEstradiolEstrogen Receptor alphaEstrogensFemaleHumansTumor MicroenvironmentEstradiolEstrogen Receptor alphaEstrogensMicroRNAsMIRN149 microRNA, humanbreast cancerestrogen receptorexosomesextracellular vesiclesmicroRNAs

Identifiers

PMID37252969
PMCPMC10266002
OpenAlexW4378782800

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.